Dermatomyositis: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/dermatomyositis.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Cyclophosphamide 3 trials
- Fludarabine 3 trials
- Anti-CD19 CAR T cell therapy 2 trials
- Baricitinib 2 trials
- Etanercept 2 trials
- 3'mRNA sequencing 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Education, coaching and self-management 1 trials · 1 completed · 0 with results
- Resistance and strength training 1 trials · 1 completed · 0 with results
- Other behavioural interventions 3 trials · 1 completed · 0 with results
- Other supplements and nutraceuticals 1 trials · 1 completed · 0 with results
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis NCT06857240
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) NCT07111065
- Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study NCT07486869